Advent Technologies Reports Q1 2022 Results
Advent Technologies Holdings (NASDAQ: ADN) reported Q1 2022 revenue of $1.3 million and grants of $0.5 million, totaling $1.8 million, a 16% increase year-over-year. However, the company posted a net loss of $(4.1) million, equating to $(0.08) per share, with operating expenses rising to $12.6 million. Cash reserves decreased to $59.3 million. Advent is advancing its next-generation MEA for testing with strategic partners and signed new contracts valued at $2.2 million for electrochemistry components. The company aims to enhance clean energy solutions and reduce emissions across various sectors.
- Q1 total revenue and grants increased by 16% year-over-year to $1.8 million.
- Cash reserves remain substantial at $59.3 million, allowing for continued investment in R&D.
- New contracts valued at $2.2 million for advanced electrochemistry components.
- Testing of next-generation MEA with strategic partners is underway, indicating potential product advancements.
- The company is actively pursuing growth in clean energy solutions and decarbonization technologies.
- Net loss of $(4.1) million for Q1, down from a profit of $2.91 million in the previous year.
- Operating expenses rose significantly by $4.7 million to $12.6 million, impacting profitability.
- Gross profit decreased to $(0.26) million, a significant decline from $1.14 million year-over-year.
-
Q1 revenue of
and income from grants of$1.3 million , for a total of$0.5 million .$1.8 million -
Net loss in Q1 of
or$(4.1) million per share.$(0.08) -
Company holds cash reserves of
as of$59.3 million March 31, 2022 . - Advent’s next-generation MEA has been provided for testing to select strategic partners.
- New contracts for advanced electrochemistry components with manufacturers of clean power generation and energy storage solutions.
Q1 2022 Financial Highlights
(all comparisons are to Q1 2021, unless otherwise stated)
-
Revenue of
and income from grants of$1.3 million in the first quarter of 2022. The total of revenue and income from grants of$0.5 million is an increase of$1.8 million 16% from the comparable total in the prior year first quarter. -
Operating expenses of
, a year-over-year increase of$12.6 million , primarily due to costs related to the accelerated growth of the Company from the acquired businesses; increased staffing and costs to operate as a public company; higher R&D costs; and stock-based compensation expenses.$4.7 million -
Net loss was
, and adjusted net loss was$(4.1) million . Adjusted net loss excludes a$(12.5) million gain from the change in the fair value of outstanding warrants.$8.4 million -
Net loss per share was
.$(0.08) -
Cash reserves were
as of$59.3 million March 31, 2022 , a decrease of from$20.5 million December 31, 2021 , driven by the increased level of R&D and administrative and selling expenses, as well as annual insurance renewals and incentive compensation payouts during the quarter.
“The consolidation of our operations, which will continue throughout 2022, has accelerated our focus across the value chain from advanced fuel cell components to fuel cell systems,” said Dr.
Q1 2022 Financial Summary
(in Millions of US dollars, except per share data) |
Three Months Ended |
||||||||
|
|||||||||
|
|
2022 |
|
|
2021 |
|
$ Change |
||
|
|||||||||
Revenue, net |
$ |
1.26 |
|
$ |
1.49 |
|
$ |
(0.23 |
) |
Gross Profit / (Loss) |
$ |
(0.26 |
) |
$ |
1.14 |
|
$ |
(1.40 |
) |
Gross Margin (%) |
|
(21 |
)% |
|
77 |
% |
|||
|
|
|
|
||||||
Operating Income/(Loss) |
$ |
(13.10 |
) |
$ |
(6.96 |
) |
$ |
(6.14 |
) |
Net Income/(Loss) |
$ |
(4.10 |
) |
$ |
2.91 |
|
$ |
(7.01 |
) |
Net Income/(Loss) Per Share (Basic) |
$ |
(0.08 |
) |
$ |
0.08 |
|
$ |
(0.16 |
) |
Net Income/(Loss) Per Share (Diluted) |
$ |
(0.08 |
) |
$ |
0.07 |
|
$ |
(0.15 |
) |
|
|
|
|
Non-GAAP Financial Measures |
|||||||||
Adjusted EBITDA – Excl Warrant Adjustment and One-
|
$ |
(11.99 |
) |
$ |
(0.89 |
) |
$ |
(11.10 |
) |
Adjusted Net Income / (Loss) – Excl Warrant
|
$ |
(12.48 |
) |
$ |
(0.99 |
) |
$ |
(11.49 |
) |
Cash and Cash Equivalents |
$ |
59.3 |
|
For a more detailed discussion of Advent’s first quarter 2022 results, please see the Company’s financial statements and management’s discussion & analysis, which are available at ir.advent.energy.
The financial results include non-GAAP financial measures. These non-GAAP measures are more fully described and are reconciled from the respective measures determined under GAAP in “Presentation of Non-GAAP Financial Measures” and the attached appendix tables.
Q1 2022 Business Updates
Advent’s Next-Generation MEAs (“Advent MEA”): On
Distribution and Service Agreement with Calscan Solutions (“Calscan”): On
Upgrade of Globe Telecom, Inc. (“Globe”) sites: On
Memorandum of Understanding (“MoU”) with
Preliminary Strategic Agreement with
Conference Call
The Company will host a conference call on
To access the call please dial (888) 660-6182 from
A replay of the call can also be accessed via phone through
About
Cautionary Note Regarding Forward-Looking Statements
This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and other words of similar meaning. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the Company’s ability to maintain the listing of the Company’s common stock on Nasdaq; future financial performance; public securities’ potential liquidity and trading; impact from the outcome of any known and unknown litigation; ability to forecast and maintain an adequate rate of revenue growth and appropriately plan its expenses; expectations regarding future expenditures; future mix of revenue and effect on gross margins; attraction and retention of qualified directors, officers, employees, and key personnel; ability to compete effectively in a competitive industry; ability to protect and enhance our corporate reputation and brand; expectations concerning our relationships and actions with our technology partners and other third parties; impact from future regulatory, judicial and legislative changes to the industry; ability to locate and acquire complementary technologies or services and integrate those into the Company’s business; future arrangements with, or investments in, other entities or associations; and intense competition and competitive pressure from other companies worldwide in the industries in which the Company will operate; and the risks identified under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the
Presentation of Non-GAAP Financial Measures
In addition to the results provided in accordance with
|
|||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||
(Amounts in thousands, except share and per share amounts) |
|||||
|
As of |
||||
ASSETS |
|
|
|
||
Current assets: |
|||||
Cash and cash equivalents |
$ |
59,282 |
|
$ |
79,764 |
Accounts receivable |
2,806 |
|
|
3,139 |
|
Contract assets |
1,090 |
|
|
1,617 |
|
Inventories |
|
9,211 |
|
|
6,958 |
Prepaid expenses and Other current assets |
10,235 |
|
|
5,873 |
|
Total current assets |
82,624 |
|
97,351 |
||
Non-current assets: |
|
|
|
|
|
|
|
30,030 |
|
|
30,030 |
Intangibles, net |
|
22,657 |
|
|
23,344 |
Property and equipment, net |
8,964 |
|
|
8,585 |
|
Other non-current assets |
|
2,523 |
|
|
2,475 |
Deferred tax assets |
1,374 |
|
|
1,246 |
|
Total non-current assets |
65,548 |
|
65,680 |
||
Total assets |
$ |
148,172 |
|
$ |
163,031 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Trade and other payables |
$ |
5,474 |
|
$ |
4,837 |
Deferred income from grants, current |
|
192 |
|
|
205 |
Contract liabilities |
558 |
|
|
1,118 |
|
Other current liabilities |
|
7,963 |
|
|
12,515 |
Income tax payable |
192 |
|
|
196 |
|
Total current liabilities |
14,379 |
|
18,871 |
||
Non-current liabilities: |
|
|
|
|
|
Warrant liability |
|
1,997 |
|
|
10,373 |
Deferred tax liabilities |
2,197 |
|
|
2,500 |
|
Defined benefit obligation |
|
95 |
|
|
90 |
Other long-term liabilities |
956 |
|
|
996 |
|
Total non-current liabilities |
5,245 |
|
13,959 |
||
Total liabilities |
19,624 |
|
32,830 |
||
Commitments and contingent liabilities |
|
|
|
|
|
Stockholders’ equity |
|
|
|
|
|
Common stock ( |
|
5 |
|
|
5 |
Preferred stock ( |
- |
|
|
- |
|
Additional paid-in capital |
|
167,755 |
|
|
164,894 |
Accumulated other comprehensive loss |
(1,691) |
|
|
(1,273) |
|
Accumulated deficit |
|
(37,521) |
|
|
(33,425) |
Total stockholders’ equity |
128,548 |
|
130,201 |
||
Total liabilities and stockholders’ equity |
$ |
148,172 |
|
$ |
163,031 |
|
|||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||
(Amounts in thousands, except share and per share amounts) |
|||||
Three months ended (Unaudited) |
|||||
2022 |
2021 |
||||
Revenue, net |
$ |
1,256 |
|
$ |
1,489 |
Cost of revenues |
(1,517) |
|
|
(347) |
|
Gross profit / (loss) |
|
(261) |
|
|
1,142 |
Income from grants |
508 |
|
|
38 |
|
Research and development expenses |
|
(2,149) |
|
|
(29) |
Administrative and selling expenses |
(10,498) |
|
|
(7,922) |
|
Amortization of intangibles |
|
(699) |
|
|
(187) |
Operating loss |
|
(13,099) |
|
|
(6,958) |
Fair value change of warrant liability |
|
8,376 |
|
|
9,766 |
Finance expenses, net |
(10) |
|
|
(10) |
|
Foreign exchange (losses) / gains, net |
|
(17) |
|
|
24 |
Other (expenses) / income, net |
(3) |
|
|
84 |
|
Income / (loss) before income tax |
|
(4,753) |
|
|
2,906 |
Income taxes |
657 |
|
|
- |
|
Net income / (loss) |
$ |
(4,096) |
|
$ |
2,906 |
Net income / (loss) per share |
|
|
|
|
|
Basic income / (loss) per share |
|
(0.08) |
|
|
0.08 |
Basic weighted average number of shares |
51,253,591 |
|
|
37,769,554 |
|
Diluted income / (loss) per share |
|
(0.08) |
|
|
0.07 |
Diluted weighted average number of shares |
51,253,591 |
|
|
40,987,346 |
|
||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||
(Amounts in thousands) |
||||||
Three months ended |
||||||
2022 |
2021 |
|||||
|
|
$ |
(19,311) |
|
$ |
(12,196) |
|
|
|
|
|||
Cash Flows from Investing Activities: |
|
|
|
|
|
|
Proceeds from sale of property and equipment |
|
0 |
|
- |
||
Purchases of property and equipment |
|
|
(950) |
|
|
(77) |
Purchases of intangible assets |
|
(13) |
|
- |
||
Advances for the acquisition of property and equipment |
|
|
(50) |
|
|
- |
Acquisition of subsidiaries, net of cash acquired |
|
|
- |
|
|
(3,976) |
Receipt of government grants |
|
|
3 |
|
|
- |
|
|
$ |
(1,010) |
|
$ |
(4,053) |
|
|
|
|
|||
Cash Flows from Financing Activities: |
|
|
|
|
|
|
Business Combination and PIPE financing, net of issuance costs paid |
|
|
- |
|
|
140,693 |
|
|
$ |
- |
|
$ |
140,693 |
|
|
|
|
|||
Net increase / (decrease) in cash and cash equivalents |
|
$ |
(20,321) |
|
$ |
124,444 |
Effect of exchange rate changes on cash and cash equivalents |
|
(161) |
|
15 |
||
Cash and cash equivalents at the beginning of the period |
|
|
79,764 |
|
|
516 |
Cash and cash equivalents at the end of the period |
$ |
59,282 |
$ |
124,975 |
||
|
|
|
|
|
|
|
Supplemental Cash Flow Information |
|
|
|
|
||
Cash activities |
|
|
|
|
|
|
Interest paid |
|
$ |
6 |
|
$ |
- |
Non-cash Investing and Financing Activities: |
|
|
|
|
|
|
Stock-based compensation |
$ |
2,861 |
$ |
- |
Supplemental Non-GAAP Measures and Reconciliations
In addition to providing measures prepared in accordance with GAAP, we present certain supplemental non-GAAP measures. These measures are EBITDA, Adjusted EBITDA and Adjusted Net Income / (Loss), which we use to evaluate our operating performance, for business planning purposes and to measure our performance relative to that of our peers. These non-GAAP measures do not have any standardized meaning prescribed by GAAP and therefore may differ from similar measures presented by other companies and may not be comparable to other similarly titled measures. We believe these measures are useful in evaluating the operating performance of the Company’s ongoing business. These measures should be considered in addition to, and not as a substitute for net income, operating expense and income, cash flows and other measures of financial performance and liquidity reported in accordance with GAAP. The calculation of these non-GAAP measures has been made on a consistent basis for all periods presented.
EBITDA and Adjusted EBITDA
These supplemental non-GAAP measures are provided to assist readers in determining our operating performance. We believe this measure is useful in assessing performance and highlighting trends on an overall basis. We also believe EBITDA and Adjusted EBITDA are frequently used by securities analysts and investors when comparing our results with those of other companies. EBITDA differs from the most comparable GAAP measure, net income / (loss), primarily because it does not include interest, income taxes, depreciation of property, plant and equipment, and amortization of intangible assets. Adjusted EBITDA adjusts EBITDA for transactional gains and losses, asset impairment charges, finance and other income and acquisition costs.
The following tables show a reconciliation of net income / (loss) to EBITDA and Adjusted EBITDA for the three months ended
EBITDA and Adjusted EBITDA |
Three months ended |
|||||
(in Millions of US dollars) |
2022 |
2021 |
$ change |
|||
Net income / (loss) |
$ |
(4.10) |
|
$ |
2.91 |
(7.01) |
Depreciation of property and equipment |
$ |
0.42 |
$ |
0.00 |
0.42 |
|
Amortization of intangibles |
$ |
0.70 |
|
$ |
0.19 |
0.51 |
Finance costs, net |
$ |
0.01 |
$ |
0.01 |
- |
|
Other (income) / expenses, net |
$ |
- |
|
$ |
(0.08) |
0.08 |
Foreign exchange differences, net |
$ |
0.02 |
$ |
(0.02) |
0.04 |
|
Income tax |
$ |
(0.66) |
|
$ |
0.00 |
(0.66) |
EBITDA |
$ |
(3.61) |
|
$ |
3.01 |
(6.62) |
Net change in warrant liability |
$ |
(8.38) |
|
$ |
(9.77) |
1.39 |
One-Time Transaction Related Expenses (1) |
$ |
0.00 |
$ |
5.87 |
(5.87) |
|
Adjusted EBITDA |
$ |
(11.99) |
|
$ |
(0.89) |
(11.10) |
(1) Bonus awarded after consummation of the Business Combination effective
Adjusted Net Income / (Loss)
This supplemental non-GAAP measure is provided to assist readers in determining our financial performance. We believe this measure is useful in assessing our actual performance by adjusting our results from continuing operations for changes in warrant liability and one-time transaction costs. Adjusted Net Loss differs from the most comparable GAAP measure, net income / (loss), primarily because it does not include one-time transaction costs and warrant liability changes. The following table shows a reconciliation of net income / (loss) for the three months ended
Adjusted Net Loss |
Three months ended (Unaudited) |
|||||
(in Millions of US dollars) |
2022 |
2021 |
$ change |
|||
Net income / (loss) |
$ |
(4.10) |
|
$ |
2.91 |
(7.01) |
Net change in warrant liability |
$ |
(8.38) |
$ |
(9.77) |
1.39 |
|
One-Time Transaction Related Expenses (1) |
$ |
0.00 |
|
$ |
5.87 |
(5.87) |
Adjusted Net Loss |
$ |
(12.48) |
|
$ |
(0.99) |
(11.49) |
(1) Bonus awarded after consummation of the Business Combination effective
View source version on businesswire.com: https://www.businesswire.com/news/home/20220512005453/en/
nhussain@advent.energy
press@advent.energy
Source:
FAQ
What was Advent's Q1 2022 revenue?
How much was Advent's net loss for Q1 2022?
What are Advent's cash reserves as of March 31, 2022?
What percentage increase did Advent experience in total revenue and grants year-over-year?